To provide a lactic acid bacterium which has an effect of preventing or ameliorating allergic symptoms, allergic disorders or inflammatory diseases, in a direction toward suppressing the secretion of IL-17 without inducing an unexpected side effect for normalizing the immune balance, and to provide fermented dairy products, medicines or drinks using the same.
The lactic acid bacterium, Streptococcus thermophilus, having a large IFN-/IL-4 with an extremely low luminescence value of IL-17 has been found by repeating tests following the test and evaluation method by stimulation of TGF-+IL-6 of Mouse Splenocytes. The therapy and amelioration of allergic symptoms, allergic disorders and inflammatory diseases can be expected, and further the immune balance can be improved to a proper state without inducing Th17. The use as a lactic acid bacteria for fermented dairy products is possible and the lactic acid bacteria can be used in medicines and drinks.
SAITO YASUO
TAKAMI KAZUYO
JPN6013036806; Ｉｎｔ．Ｊ．Ｍｏｌ．Ｍｅｄ．，Ｖｏｌ．２２（Ａｕｇ．２００８）ｐ．１８１-１８５
JPN6013054924; 食品工業技術センターニュース，Ｎｏ．２６（Ｊａｎ．２００８）ｐ．２
Next Patent: FISHING REEL